GTG, bought yesterday cos of announcement to develop colorectal cancer risk assessment test.. In short GTG crate test kits & are now branching out into other diseases.
Dual listed GENE which lists on the Nasdaq, closed 65% up..
Short Term trading Week Starting: 28 Nov, page-258
-
- There are more pages in this discussion • 277 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)